Oxyview ®

SMART Nasal Cannula TM Introducing Oxyview ® Oxyview ® is a safety device and the world's first in-line oxygen flow-meter. The Oxyview ® quickly turns your nasal cannula into a Smart Nasal Cannula that is capable to monitoring your oxygen flow, while at the same time assures proper equipment function. This is a low cost solution that provides an easy to read, real time accurate measurement of continuous oxygen flow. A disposable high-quality latex-free soft-tip cannula with an In-Line Oxyview that is maintenance free. “Self Monitoring Advanced Respiratory Technology” offers the patient the same piece of mind as Oxyview itself but in a single package. Smart Nasal Cannula w/ Oxyview comes in sizes: - Adult - Child - Infant and in flows of 0-3 and 0-6 liters per minute - Oxyview ® Monitors real-time oxygen flow rate continuously ! - Oxyview ® Assures proper function of your oxygen equipment including your regulator and tank ! - Oxyview ® Provides additional safety and assurance to home oxygen patients who rely on oxygen therapy !

Revolutionary Oxyview Flow-Meter In-line with cannula, near patient Works in any position (non-gravity dependent) Patient Friendly and Durable Lightweight Inexpensive More Accurate Allows clinician to see oxygen flow during rehab and at home when a patient requires extenders to be attached to their nasal cannula for mobility Patients using a low flow oxygen can quickly verify oxygen flow even though they do not always feel the gas flow. Improves Oxygen Therapy

Oxyview ® is a flow-meter. Oxyview ® mounts between the cannula and the tank “in-line” Oxyview ® delivers an easily read confirmation of actual flow Oxyview ® is the worlds first gravity independent flow-meter Oxyview ® is pneumatic and requires no batteries Oxyview ® can be used with oxygen devices including: Concentrators CPAPs Gas or liquid oxygen tanks And other oxygen equipment Equipment can be placed at any distance from the patient since Oxyview ® can be mounted close to the patient and “in-line” with the oxygen tubing. Oxyview ® can quickly verify to the patient/caregiver the correct oxygen flow, leaks or malfunction in the regulator or respiratory equipment. Oxyview ® is the new generation of pneumatic safety devices needed in the growing oxygen therapy market. What Is Oxyview ® ?

ISO 13485:2003 Certified FDA Registered DHS Licensed CMS Medicare Approved Reimbursement Code Made in the USA

Adjustable over-the-ear style Soft non-flared nasal top One piece seamless design Clear lightweight tubing Crush-resistant tubing Latex-free safe material construction Oxyview® inline Flow-Meter Life-Time Warranty

Conventional Flow-Meters $52$55$43$895 Attach at the tank, distant from patient Only works upright (gravity) Bulky Heavy Expensive Less Accurate

Differences Oxyview ® Conventional Flow-Meters Oxyview works in any direction, hands-free, using several controlled forces to include oxygen flow, cyclonic induction and Ingen's patented proprietary gravity-independent spring technology. Conventional flow-meters work on two forces, oxygen flow and gravity. Oxyview is 90%-100% accurate in any position regardless of friction, moisture, vibration, temperature or position. Further, because of the accuracy, faulty regulators and other gauges can be identified. Oxyview can be mounted near the cannula. This allows for exact flow rate measurement. It can help the patient with problems associated with tubing obstruction. Oxyview is strong and lightweight. The polycarbonate construction is rust resistant and stronger than steel or brass. The Oxyview can be installed in less than a minute without using any special wrench. Conventional flow-meters are 20-30% inaccurate due to several reasons: Friction… ball inside rubs against the walls. Moisture… water vapor will build-up inside. Vibration… sound and movement causes more friction. Temperature….inside material contracts & expands. Position…device must be perpendicular to the earth. Conventional Flow Meters are heavy and made of steel, glass and brass. They are subject to weather defects and will crack. These devices can only be mounted on the tank and requires special tools and knowledge. Conventional flow meters are costly to purchase and replace. It is not a simple fix.

Home Care & Assisted Living More and more people are using oxygen therapy outside the hospital, permitting them to lead active, productive lives. People with asthma, emphysema, chronic bronchitis, occupational lung disease, lung cancer, cystic fibrosis, or congestive heart failure may use oxygen therapy at home. Home oxygen therapy accounts for the largest share of Medicare payments for durable medical equipment. Oxyview allows home care patients to live relatively “Worry Free” by providing peace-of-mind at minimal cost Confirmation that DME equipment is functioning properly Determine if flow is reduced by addition of humidifier bottle Assurance that prescribed flow is being supplied through the cannula Accurately read meter whether person is sitting, standing or sleeping.

Market Research Data 8-9% of Americans suffer from respiratory conditions such as: Asthma COPD Bronchitis The largest respiratory market is asthma. Oxyview applies to the non-asthma markets which represents $4Billion today and will increase to $6Billion by Despite the delivery apparatus, Oxyview can participate in the $4-$6 Billion market because reliable oxygen therapy is critical to all patients, caregivers and suppliers. Opportunities for Oxyview in the home health care setting are driven by the convergence of two trends:  First, the segment of the US population aged 65 and over will double by 2015  Second, there is a concerted drive to move patients from the hospital to the home care setting as quickly as possible. Oxygen and respiratory manufacturers are competing aggressively for new patients by introducing new, easier-to-use equipment. An extensive study performed by In-Touch Life Sciences, LLC indicates that Oxyview can be a successful medical device for the oxygen therapy market place.

8-9% US Market Market Projections 11,500,000 Americans have COPD, increasing 5-6% annually Aging population increasing for the 55+ target audience Smoking prevalence in men & women 800,000 severe COPD cases receive constant oxygen therapy 640,000 Oxygen Concentrators 140,000 Liquid Oxygen portable units COPD is major cause of hospitalizations and 5 th leading cause of death in the US 38,000,000 COPD sufferers in US, EC and Japan Annual sales will increase as follows: Oxygen system sales will increase from $618M to $954M by 2012 Airway Mgt Device sales will increase from $599M to $815M by 2012 Nebulizer sales will increase from $600M to $879M by 2012 Ventilator sales will increase from $718M to $1B by 2012 Humidifier sales will increase from $763M to $1B by 2012 Pulse Oximeter sales will increase from $1.1B to $1.9B by 2012 PAP sales will increase from $218M to $299M by 2012 Overall, respiratory has had excellent growth of 17% per annum since 1997 with projected growth of 10% per year for the next few years.

Other Markets for Oxyview Aviation (Commercial and Private)‏ Emergency Response (Ambulance and Paramedics)‏ Fire Department Military and Department of Defense

Thank You!